France's Boiron Diversifies Into Probiotics To Arrest Sales Decline
Executive Summary
Homeopathy specialist Boiron its diversifying its offering into the increasingly popular probiotics segment with launches underway in France, Italy and Spain, as well as Eastern Europe.
You may also be interested in...
France's Boiron Reaping The Benefits Of Product Investments
Boiron's decision to diversify its portfolio away from non-proprietary homeopathic medicines is paying off, with sales for the opening nine months of 2022 up by a quarter, driven by new product launches in categories such as cosmetics and dietary supplements.
Boiron Partners With Galenica's Verfora In Switzerland
France's Boiron has granted Galenica's Verfora the rights to distribute in Switzerland its portfolio of over 800 products as it looks to turnaround its business and make cost savings following the collapse of homeopathy sales in its home market.
Boiron Posts Big Sales Gain As It Benefits From Easy Comp
French homeopathy specialist Boiron reported sales up by 60% in Q1 as the business returned to growth following the end of COVID-19 social restrictions.